One patient, OS-250, carried a germline RET mutation, which at the time of diagnosis had not yet manifested by multiple endocrine neoplasia type 2 but the mutation co-segregated with breast cancer and rhabdomyosarcoma in two first-degree relatives. Here, RET is linked to breast cancer.